ArticleFrontiers in medicine2026
NPHR, FPR, and PLT as predictors of ulcerative colitis severity: a single-center retrospective study in China.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ulcerative colitis (UC) is a chronic inflammatory bowel disease, and precise evaluation of disease activity is essential for effective management. This study aimed to assess the value of the peripheral-blood neutrophil percentage-to-hemoglobin ratio (NPHR), fibrinogen-to-prealbumin ratio (FPR), and platelet count (PLT) in identifying moderate-to-severe UC and to develop a predictive model for clinical risk stratification. Methods: Data from 277 hospitalized UC patients, consecutively admitted to the Department of Gastroenterology at the Affiliated Hospital of Jining Medical University between May 2023 and October 2025, were retrospectively analyzed. Disease activity was classified based on the modified Mayo score into low-activity (remission or mild) and moderate-to-severe groups. Independent predictors were identified using multivariable logistic regression and incorporated into a nomogram. Discrimination and calibration were assessed via receiver operating characteristic (ROC) curves and calibration curves, respectively. Clinical utility was evaluated through decision curve analysis (DCA) and the clinical impact curve (CIC). Results: NPHR, FPR, and PLT were independent risk factors for moderate-to-severe UC ( Conclusion: NPHR, FPR, and PLT are independent predictors of moderate-to-severe UC. The combination of these markers enhances predictive accuracy and provides a valuable tool for disease activity assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.